دورية أكاديمية

AMFR drives allergic asthma development by promoting alveolar macrophage-derived GM-CSF production.

التفاصيل البيبلوغرافية
العنوان: AMFR drives allergic asthma development by promoting alveolar macrophage-derived GM-CSF production.
المؤلفون: Zhang H; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, P.R. China., Wei R; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China., Yang X; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, P.R. China., Xu L; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, P.R. China., Jiang H; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, P.R. China., Li M; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, P.R. China., Jiang H; School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, P.R. China., Zhang H; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, P.R. China., Chen Z; Department of Respiratory and Critical Care Medicine of Zhongshan Hospital, Shanghai Institute of Respiratory Disease, Fudan University, Shanghai, P.R. China., Qian F; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, P.R. China., Sun L; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, P.R. China.
المصدر: The Journal of experimental medicine [J Exp Med] 2022 May 02; Vol. 219 (5). Date of Electronic Publication: 2022 Mar 25.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Rockefeller University Press
مواضيع طبية MeSH: Asthma* , Macrophages, Alveolar*/metabolism , Receptors, Autocrine Motility Factor*/metabolism, Granulocyte-Macrophage Colony-Stimulating Factor/metabolism ; Humans ; Inflammation/metabolism
مستخلص: Alveolar macrophages (AMs) are specialized tissue-resident macrophages that orchestrate the immune response in allergic inflammation and asthma. However, what signals direct AMs to cross talk with other immune cells remains unclear. Here, we report that autocrine motility factor receptor (AMFR), an endoplasmic reticulum-resident E3 ubiquitin ligase, is upregulated in AMs of asthma and is critical for this condition. AMFR deficiency significantly decreased allergy-induced T helper 2 (Th2) and eosinophilic inflammation, with less granulocyte-macrophage colony-stimulating factor (GM-CSF) production in AMs. Mechanistically, following thymic stromal lymphopoietin (TSLP) stimulation, AMFR associated directly with cytokine-inducible SH2-containing protein (CIS), induced the ubiquitination of Lys48-linked polyubiquitination of CIS, and consequently blocked the inhibitory effect of CIS on signal transducer and activator of transcription 5 (STAT5) phosphorylation and the downstream pathway activation in AMs. In conclusion, our results demonstrate that AMFR serves a crucial role in promoting inflammation in asthma through regulating AM function, and may emerge as a new potential drug target for asthma therapy.
(© 2022 Zhang et al.)
References: Nat Commun. 2014 Aug 22;5:4732. (PMID: 25145352)
Nat Med. 2013 Feb;19(2):232-7. (PMID: 23334847)
Immunol Cell Biol. 2019 Mar;97(3):246-257. (PMID: 30768869)
J Immunol Res. 2018 May 3;2018:3823910. (PMID: 29854835)
Am J Physiol Lung Cell Mol Physiol. 2018 Sep 1;315(3):L371-L381. (PMID: 29770701)
Biochem Pharmacol. 2018 Sep;155:198-206. (PMID: 29991449)
J Exp Med. 2021 Oct 4;218(10):. (PMID: 34431978)
Nat Rev Immunol. 2018 Feb;18(2):121-133. (PMID: 29082915)
Semin Immunopathol. 2020 Feb;42(1):5-15. (PMID: 32020334)
J Mol Cell Biol. 2015 Dec;7(6):557-67. (PMID: 26101328)
Am J Physiol Lung Cell Mol Physiol. 2017 Jul 1;313(1):L104-L114. (PMID: 28522566)
Nature. 2017 Aug 17;548(7667):338-342. (PMID: 28792938)
Nat Rev Immunol. 2011 Dec 09;12(1):35-48. (PMID: 22158412)
Blood. 2004 May 15;103(10):3744-50. (PMID: 14764533)
Nat Immunol. 2013 Jul;14(7):732-40. (PMID: 23727894)
Allergol Int. 2015 Jul;64(3):227-34. (PMID: 26117253)
Ann Am Thorac Soc. 2013 Dec;10 Suppl:S118-24. (PMID: 24313761)
Cell Res. 2016 Apr;26(4):457-83. (PMID: 27012466)
J Neurochem. 2002 Jan;80(2):354-61. (PMID: 11902125)
Nat Med. 2012 May 04;18(5):673-83. (PMID: 22561831)
J Immunol. 1999 Dec 1;163(11):5971-7. (PMID: 10570284)
Semin Immunol. 2007 Jun;19(3):197-205. (PMID: 17433711)
J Allergy Clin Immunol. 2021 Jun;147(6):2118-2133.e3. (PMID: 33440200)
Mol Biol Cell. 2013 Apr;24(8):1153-62. (PMID: 23427266)
Trends Immunol. 2020 Oct;41(10):864-877. (PMID: 32896485)
Immunity. 2019 Apr 16;50(4):975-991. (PMID: 30995510)
Immunity. 2014 Dec 18;41(6):919-33. (PMID: 25526307)
Nature. 2007 May 3;447(7140):92-6. (PMID: 17450126)
Pharmacol Res. 2020 Aug;158:104884. (PMID: 32428667)
J Immunol. 2017 Jun 1;198(11):4470-4480. (PMID: 28455433)
Cell Immunol. 2018 Aug;330:86-90. (PMID: 29370889)
Science. 2015 Sep 4;349(6252):1106-10. (PMID: 26339029)
Nat Immunol. 2016 Jul;17(7):816-24. (PMID: 27213690)
J Biol Chem. 2011 Jun 10;286(23):20835-44. (PMID: 21507957)
Mol Biosyst. 2009 Aug;5(8):793-801. (PMID: 19603112)
J Allergy Clin Immunol. 2019 Apr;143(4):1513-1524.e2. (PMID: 30244025)
Medicine (Baltimore). 2017 Sep;96(35):e7667. (PMID: 28858086)
Front Cell Neurosci. 2017 Aug 25;11:259. (PMID: 28890687)
Immunity. 2021 Oct 12;54(10):2433-2435. (PMID: 34644559)
Pharmacol Ther. 2021 Jan;217:107648. (PMID: 32758645)
Cell Rep. 2014 Feb 27;6(4):709-23. (PMID: 24508458)
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14422-7. (PMID: 11724934)
Nat Rev Immunol. 2015 Jan;15(1):57-65. (PMID: 25534623)
N Engl J Med. 2017 Sep 7;377(10):936-946. (PMID: 28877011)
Cytokine Growth Factor Rev. 2013 Dec;24(6):559-70. (PMID: 23953672)
Nat Med. 2014 Nov;20(11):1242-53. (PMID: 25375928)
J Exp Med. 2005 Sep 19;202(6):829-39. (PMID: 16172260)
Trends Immunol. 2009 Dec;30(12):592-602. (PMID: 19879803)
J Allergy Clin Immunol. 2021 Mar;147(3):1087-1092.e3. (PMID: 33065121)
J Allergy Clin Immunol. 2020 Dec;146(6):1406-1418.e7. (PMID: 32304753)
Immunology. 2020 Jun;160(2):126-138. (PMID: 31715003)
معلومات مُعتمدة: 81973329 National Natural Science Foundation of China; 21ZR1432700 Natural Science Foundation of Shanghai; 19X160010005 Shanghai Jiao Tong University
المشرفين على المادة: 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor)
EC 2.3.2.27 (AMFR protein, human)
EC 2.3.2.27 (Receptors, Autocrine Motility Factor)
تواريخ الأحداث: Date Created: 20220325 Date Completed: 20220418 Latest Revision: 20221102
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8961293
DOI: 10.1084/jem.20211828
PMID: 35333296
قاعدة البيانات: MEDLINE
الوصف
تدمد:1540-9538
DOI:10.1084/jem.20211828